sterna biologicals wins second place in Science4Life Venture Cup contest 2007
sterna biologicals announced that the company has won second place in Germany´s most important business plan contest in the fields of biotechnology, life sciences and chemistry. Science4Life is an independent German initiative that offers assistance to founders of start-up companies and young entrepreneurs in the fields of biotechnology, life sciences and chemistry. It is co-sponsored by the county government of Hesse and Sanofi-Aventis, and is actively supported by more than 100 respected companies, institutions, and non-profit organizations. It´s major activity is the annual business plan competition in the fields of life sciences and chemistry.
More than 200 start-up companies and teams of founders attended this year´s contest for the best ideas and concepts in bringing innovative products and services to the marketplace. 47 detailed business plans entered the final round and were evaluated by scientific and business experts in the field. The five best-ranked teams were invited to attend a 4 days high-class business founder workshop at the end of which they presented their business concepts in front of a jury with distinguished members from the fields of science, business and finance.
sterna biologicals is delighted that the company´s plan to develop DNAzymes as 3rd generation of antisense drugs for the treatment of chronic inflammatory diseases has been highly appreciated and honoured by the experts and the jury. Holger Garn, the Chief Executive Officer of sterna biologicals commented: "We are very honoured that our company receives such a highly distinguished award, which recognizes the importance of addressing key targets at the most earliest stage of the disease development. This success, however, was also made possible by the professional assistance by Tytonis and its network partners Apis Pharma and TransformRx."
Weitere News aus dem Ressort Wirtschaft & Finanzen
Holen Sie sich die Life-Science-Branche in Ihren Posteingang
Ab sofort nichts mehr verpassen: Unser Newsletter für Biotechnologie, Pharma und Life Sciences bringt Sie jeden Dienstag und Donnerstag auf den neuesten Stand. Aktuelle Branchen-News, Produkt-Highlights und Innovationen - kompakt und verständlich in Ihrem Posteingang. Von uns recherchiert, damit Sie es nicht tun müssen.
